Literature Decoded

Living reprintoriginally published in Orthopaedic Surgery 2026CC BY 4.0Read the version of record Opt out

Literature DecodedLiving reprint
Living reprint · journal article Journal version available

Perioperative Factors Associated With Allogeneic Blood Transfusion in Elective THA

Study first published in Orthopaedic Surgery (2026), reprinted in full under its CC BY 4.0 licence.

Reprinted 2026-10-01 19 min read Living reprint · journal article Version of record: Orthopaedic Surgery 2026Licence: CC BY 4.0

Reading mode
In plain languageStudy first published in Orthopaedic Surgery (2026), reprinted in full under its CC BY 4.0 licence.

Study first published in Orthopaedic Surgery (2026), reprinted in full under its CC BY 4.0 licence.

No plain-language summary has been written for this reprint yet. The authors' abstract and full text follow, unchanged apart from layout.

Educational summary of research findings; not medical advice. Discuss care decisions with a qualified clinician.

Bottom line

What the evidence supports

How to read it

No plain-language summary has been written for this reprint yet. The authors' abstract and full text follow, unchanged apart from layout.

Limitations

The findings apply to the included study populations and may not generalise to every person or setting.

Disclaimer

Educational summary of research findings; not medical advice. Discuss care decisions with a qualified clinician.

The paper

Full manuscript

Abstract

Background

Identifying predictors of perioperative blood transfusion is essential for optimizing patient safety and perioperative blood management in total hip arthroplasty (THA). This Study aimed to identify perioperative factors independently associated with transfusion.

Methods

This retrospective study included all elective primary THA procedures performed between 2016 and 2023 at a certified Endoprosthetic Center. Demographic, clinical, laboratory, and operative variables were extracted. Total and hidden blood loss were calculated using the Nadler and Gross/Sehat formulas. A multivariable logistic regression model was fitted to identify independent factors associated with transfusion. Receiver operating characteristic (ROC) analyzes were performed for cup inclination and the 48‐h hematocrit. Cutoff thresholds were derived using Youden's index, and combined decision rules (AND/OR) were evaluated.

Results

Among 39 predictors, three variables were independently associated with transfusion: cup inclination (OR = 0.89; p = 0.0003), 48‐h hematocrit (OR ≈5.17 × 10−48; p = 0.023), reflecting quasi‐separation due to a near‐deterministic threshold effect rather than a literal effect size, and reoperation (OR = 13.19; p = 0.049). The model demonstrated excellent discrimination (AUC = 0.931). Inclination alone showed negligible predictive value (AUC = 0.393). The 48‐h hematocrit was a strong single predictor (AUC = 0.817) with a clinically meaningful threshold (< 0.28 L/L). Combined rules showed moderate performance; the OR rule was ineffective.

Conclusion

Early postoperative hematocrit is a robust and clinically actionable marker associated with transfusion risk in primary THA. Cup inclination reflects the surgical technique rather than direct transfusion risk, and reoperation likely indicates underlying perioperative complexity. Transfusion strategies should prioritize hematocrit‐based evaluation rather than inclination‐based thresholds.

Level of Evidence

III—retrospective single‐center observational cohort study.

Keywords: blood transfusion; hematocrit; hidden blood loss; predictors; total hip arthroplasty

Overview

Abbreviations

ASA
American Society of Anesthesiologists
AUC
Area Under the Curve
BMI
Body Mass Index
CI
Confidence Interval
CS
Cannulated Screw
DHS
Dynamix Hip Screw
DVT
Deep Vein Thrombosis
EPZ
Endoprosthetic Center
FPR
Wrong Positive Rate
GT
Great Trochanter
HBL
Hidden Blood Loss
Hb
hemoglobin
Hct
hematocrit
HHS
Harris Hips Score
MCH
mean corpuscular hemoglobin
MCHC
mean corpuscular hemoglobin concentration
MCV
mean corpuscular volume
NPV
Negative Predictive Value
OR
Odds Ratio
PBM
Patient Blood Management
PE
Pulmonary Embolism
PPV
Positive Predictive Value
PRBC
Packed Red Blood Cells
RBC
red blood cells
RCT
Randomized Controlled Trial
ROC
Receiver Operating Characteristic
SE
Standard Error
STROBE
Strengthening the Reporting of Observational Epidemiology
THA
total hip arthroplasty
TRALI
transfusion‐related acute lung injury
TXA
tranxeamic acid

Introduction

Total hip arthroplasty (THA) is one of the most successful orthopedic interventions, reliably improving quality of life through pain relief and restoration of mobility. Nonetheless, substantial perioperative blood loss, both overt and hidden, remains a frequent and clinically important challenge. The resulting decline in hemoglobin often necessitates allogeneic blood transfusion, which, while sometimes life‐saving, is associated with significant risks including immunologic reactions, infection, transfusion‐related acute lung injury (TRALI), prolonged hospitalization, and even increased mortality1. Identifying patients at greatest risk for transfusion is therefore essential to improve perioperative planning and support blood conservation strategies.

A wide range of predictors of transfusion risk has been described. Systematic reviews and large database analyzes consistently highlight patient and procedure related factors such as preoperative anemia, female sex, advanced age, low body mass index (BMI), high American Society of Anesthesiologists (ASA) classification, surgical drainage, and conversion from prior procedures as important contributors2, 3, 4, 5. Medication use also plays a role: continuation of antiplatelet therapy markedly increases transfusion likelihood, whereas administration of tranexamic acid (TXA) has been shown to significantly reduce perioperative blood loss and transfusion requirements6, 7.

In this context, Patient Blood Management (PBM) programs have been developed as multimodal approaches to reduce dependence on transfusion. Preoperative hemoglobin optimization in particular has demonstrated benefit, leading not only to decreased transfusion demand but also to shorter hospital stays and more favorable discharge outcomes8, 9. Despite these advances, preoperative anemia remains highly prevalent, affecting approximately one in five patients undergoing joint replacement, with even higher rates reported in revision surgery10.

Yet, considerable heterogeneity persists in reported transfusion rates and thresholds across studies and institutions, limiting generalizability. More importantly, few large‐scale investigations have integrated both patient‐specific and surgical variables to determine which factors most strongly predict transfusion in modern elective THA cohorts.

The aims of this retrospective study were threefold: (1) to identify perioperative factors independently associated with allogeneic blood transfusion in elective primary THA within a contemporary PBM‐guided setting; (2) to compare the relative predictive and discriminatory performance of patient‐specific laboratory markers versus procedural and technical variables; and (3) to evaluate the clinical utility and limitations of cutoff‐based decision rules for early postoperative transfusion risk stratification.

Methods

Study Context

This retrospective analysis was conducted in accordance with STROBE guidelines11 and forms part of the Brandenburg THA Blood Management Series. All elective primary THAs performed at the Endoprosthetic Center (EPZ) of the University Hospital Brandenburg/Havel between 1 January 2016 and 31 December 2023 were identified through the institutional registry (> 1400 cases). Ethical approval for all retrospective evaluations was granted by the Ethics Committee of the University of Brandenburg (No. 292032025‐BO‐E‐RETRO).

Data Extraction

Two investigators (NR, DF) independently extracted data from the electronic hospital information system. Operative reports, anesthesia records, discharge summaries, and internal quality assurance forms were reviewed. Extracted variables included demographics (age, sex, height, weight), BMI (calculated), ASA class, surgical indication, surgeon experience, operative time, cement use, intra‐ and postoperative complications, reoperations, transfusion events (yes/no, number of RBC units), and laboratory values (RBC, Hb, Hct, MCV, MCH, MCHC). Postoperative labs were captured at predefined intervals (≤ 48 h, postoperative days 3–6, ≥ 7 days) and immediately before/after transfusion. During the entire study period (2016–2023), transfusion decisions followed institutional Patient Blood Management–oriented standards, primarily based on hemoglobin thresholds in combination with clinical symptoms (e.g., hemodynamic instability, signs of hypoxia), rather than isolated laboratory values. These criteria were applied consistently across treating physicians as part of routine clinical practice. Cup inclination was measured on standardized postoperative anteroposterior pelvic radiographs according to institutional routine. All procedures were performed within a certified Endoprosthetic Center following standardized perioperative workflows by experienced surgeons. Surgeon experience was operationalized as a categorical binary variable based on institutional certified Endoprosthetic Center classification, distinguishing procedures performed by the designated primary consultant surgeon (“Hauptoperateur”) from those performed by non‐primary surgeons. Surgeon experience was not modeled as a continuous variable, nor quantified by years of practice or cumulative case volume. Disagreements in data extraction were resolved by consensus. Missing predictor values were handled by complete‐case analysis. Cases with missing data required for the calculation of hidden blood loss (HBL) were excluded, resulting in a complete‐case analysis for all variables included in the regression model.

Blood Loss Calculations

Individual blood volume was calculated using the Nadler formula12. Total blood loss was estimated using the Gross/Sehat dilution method. Measured blood loss was taken from the intraoperative suction volume. HBL was defined as:

Total blood loss–(suction loss+transfused volume).

One packed red blood cell (PRBC) unit was assumed to equal 260 mL unless documented otherwise.

Logistic Regression Analysis

A multivariable logistic regression model was fitted to identify independent factors associated with allogeneic red blood cell transfusion. All available demographic, laboratory, and procedural variables were entered simultaneously without prior feature reduction. The dependent variable was transfusion (yes/no). Continuous variables were used as linear terms; categorical variables were dummy‐coded. Odds ratios (OR) with 95% confidence intervals (CI) were computed. Multicollinearity diagnostics were not formally performed. Model discrimination was evaluated using the area under the receiver operating characteristic curve (AUC). Formal multicollinearity diagnostics (e.g., variance inflation factors) and alternative regression strategies were not applied, as the model was intended for exploratory risk discrimination rather than coefficient optimization or causal inference. Given the inclusion of multiple biologically related hematologic variables, some degree of multicollinearity was expected and individual coefficient estimates were therefore interpreted with caution.

ROC Analysis and Cutoff Selection

Univariate receiver operating characteristic (ROC) analyzes were conducted for two single predictors: cup inclination (degrees) and 48‐h hematocrit (l/l). Optimal cutoffs were identified using Youden's index and then clinically rounded. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were computed for each threshold.

Two combined decision rules were evaluated using the rounded thresholds:

  • AND rule: inclination < tIncl and Hct < tHct
  • OR rule: inclination < tIncl or Hct < tHct

Results

Cohort and Descriptive Characteristics

A total of 648 primary THA were included in the final analysis after exclusion of cases lacking sufficient data to calculate HBL, resulting in a complete‐case analytic cohort (Figure 1). Overall, 104 patients (16.0%) received at least one allogeneic red blood cell transfusion during the index hospital stay, while 544 patients (84.0%) were not transfused. The cohort had a mean age of 70.8 ± 10.3 years (median 71.5), with women accounting for 57.6% of all patients. Uncemented implants were used in 84.6% of procedures, and standard straight stems in 66.5%. Primary osteoarthritis was the dominant indication, accounting for 91.4% of cases. The mean duration of surgery was 72.0 ± 22.9 min, and mean intraoperative measured blood loss was 529.8 ± 311.1 mL. Calculated total blood loss averaged 1372 ± 504 mL (median 1335), while mean HBL amounted to 854.9 ± 443 mL (median 824). Postoperative complications were infrequent, with a reoperation rate of 2.0%. A detailed summary of baseline variables is presented in Table 1.

Figure 1
Figure 1. Flow diagram illustrating case selection for the final analysis. From all elective primary total hip arthroplasties performed during the study period, procedures lacking sufficient data to calculate hidden blood loss were excluded. This resulted in a final analytic sample of 648 complete cases. The flow structure aligns with the Statement Guidelines for Reporting Observational Studies (STROBE) for transparent reporting of inclusion and exclusion steps in observational cohort studies. HBL, hidden blood loss; ROC, receiver operating characteristic.
Table 1. Baseline characteristics of the analyzed patient cohort (N = 648) undergoing elective primary THA.
ParameterValues
Preoperative data
Patient age (years)70.82 ± 10.32
Median: 71.5 (28; 93)
SexMale: 275 (42.4%)
Female: 373 (57.6%)
OperatorSenior: 619 (95.5%)
Trainee: 29 (4.5%)
CementUncemented: 548 (84.6%)
Cemented: 100 (15.4%)
StemStandard straight stem: 431 (66.5%)
Short stem: 217 (33.5%)
IndicationOA: 592 (91.4%)
Post‐traumatic OA: 15 (2.3%)
ANFH: 23 (3.5%)
DDH: 17 (2.6%)
Cancer: 1 (0.2%)
Weight83.24 ± 18.43
Median: 80 (41; 160)
Height168 ± 9.3
Median: 168 (139; 195)
BMI29.37 ± 5.36
Median: 28.72 (16.42365006; 49.39307851)
ASA1: 39 (6%)
2: 335 (51.8%)
3: 270 (41.7%)
4: 3 (0.5%)
Perioperative data
Operative time72.04 ± 22.94
Median: 68 (36; 277)
Intraoperative blood loss529.8 ± 311.1
Median: 500 (50; 3000)
Total blood loss1372 ± 504
Median: 1335 (0; 3079)
HBL854.9 ± 443
Median: 824 (0; 2579)
Inclination41.08 ± 5.15
Median: 41 (22; 57)
Complications
DVT/PENo: 646 (99.7%)
Yes: 2 (0.3%)
InfectionNo: 643 (99.2%)
Yes: 5 (0.8%)
DislocationNo: 646 (99.7%)
Yes: 2 (0.3%)
GT avulsionNo: 644 (99.4%)
Yes: 4 (0.6%)
Periprosthetic fractureNo: 640 (98.8%)
Yes: 8 (1.2%)
Nerve injuryNo: 648 (100%)
Yes: 0 (0%)
Death and reoperation
DeathNo: 646 (99.7%)
Yes: 2 (0.3%)
ReoperationNo: 635 (98%)
Yes: 13 (2%)

Note: Continuous variables are presented as mean ± standard deviation or median (range), while categorical variables are shown as absolute numbers and percentages. Total perioperative blood loss averaged 1372 ± 504 mL, and calculated HBL averaged 854.9 ± 443 mL (median 824 mL). Uncemented implant fixation accounted for 84.6% of procedures, and the overall reoperation rate was low at 2.0%.

Abbreviations: ANFH, avascular necrosis of the femoral head; ASA, American Society of Anesthesiologists; BMI, body mass index; DDH, developmental dysplasia of the hip; DVT, deep vein thrombosis; GT, greater trochanter; HBL, hidden blood loss; OA, osteoarthritis; PE, pulmonary embolism; THA, total hip arthroplasty.

Results of Multivariable Logistic Regression

The multivariable logistic regression model included 39 predictors (28 continuous and 11 categorical variables) and was based on 104 transfusion events, corresponding to an approximate events‐per‐variable ratio of 2.7. Accordingly, the model was intended for exploratory risk discrimination rather than precise coefficient estimation or causal inference (Table 2). Cup inclination showed a protective effect: each additional degree of inclination was associated with an 11% reduction in the odds of receiving a transfusion (OR = 0.89, 95% CI 0.84–0.95; p = 0.0003). However, when considered as a standalone predictor, cup inclination demonstrated poor discriminatory performance (AUC = 0.393), indicating limited clinical utility despite statistical significance in the multivariable model. In contrast, the 48‐h hematocrit demonstrated a very strong inverse relationship with transfusion risk, reflected by an extremely small odds ratio (OR ≈5.17 × 10−48, 95% CI 6.38 × 10−89–4.20 × 10−7; p = 0.023), indicating that lower hematocrit values at 48 h were strongly predictive of transfusion. Reoperation during the hospital stay was also significantly associated with transfusion, increasing the odds more than 13‐fold (OR = 13.19, 95% CI 1.01–171.40; p = 0.049). Overall, the model demonstrated excellent discriminatory performance (AUC = 0.931), which should be interpreted as exploratory (Figure 2).

Table 2. Full multivariable logistic regression model for perioperative transfusion.
PredictorLogistic regression coefficient βSEz‐valuepORLower 95% CIUpper 95% CI
Inclination (°)−0.1150527770.032090486−3.585261320.0003367410.8913191010.8369851310.949180232
48 h postoperative Hct (l/l)−108.880375348.06025434−2.2654972760.0234821815.17433E‐486.38104E‐894.19582E‐07
Reoperation (Yes/No)2.5792473341.3085614141.9710556240.04871751413.187208851.014619932171.3966697
ASA_Patient with severe systemic disease that is a constant threat to life3.6510037621.8876247951.9341787480.05309115438.513304830.9524926841557.255686
ASA_Patient with severe systemic disease1.8847803730.9995492041.8856304070.0593447776.5849080580.92839307146.70544782
Intraoperative blood loss (mL)0.0184899640.0102864471.7975073640.072255111.0186619620.9983302941.039407698
Total blood loss (mL)−0.0181902480.010774986−1.688192280.0913743250.9819741960.9614537361.002932628
HBL (mL)0.0163197890.0103760841.5728273810.1157587941.0164536850.9959910951.037336677
Erythrozyten 48 h postoperativ in 1012/L4.9547980513.3913226651.4610223030.144009321141.85395620.184137553109279.9628
Indication—posttraumatic2.2605039591.5474688241.4607751210.1440771669.5879198660.461866586199.0362804
Patient age (years)0.0434233630.0315173561.3777603120.1682773031.0443799530.9818178071.110928604
Operative time (min.)0.0121504270.0089527521.3571722610.1747264821.0122245440.9946178911.030142868
Indication—osteoarthritis1.8234017951.3493645321.3513040780.1765980466.19288960.43985766787.19157241
Indication—dysplasia2.0010329041.625979231.2306632620.2184488347.3966922260.305493179179.0909245
Cement usage_(Yes/No)−0.5041302250.424243473−1.1883040220.2347136540.6040307180.2629918721.38731705
WHO BMI_obesity class III2.8267253922.388572021.1834373710.23663585416.890061840.1564858421823.003191
ASA_Patient with mild systemic disease1.1210162240.9701836841.1554680250.2478988193.0679703660.45817280920.54343249
Infection (Yes/No)−2.4241159552.258068957−1.0735349550.2830311640.0885563720.0010596157.401020341
DVT/PE (Yes/No)2.067073492.0088752321.0289705690.3034935057.9016649450.154085195405.2064111
Periprosthetic fracture (Yes/No)1.1098255671.1755830270.9440639590.3451369653.0338291480.30292354630.38429797
Age groups_Young0.5415493380.6487467890.8347622630.4038515771.7186675970.4819229646.129233362
Height0.2183199860.2836543940.7696689730.441496281.2439850620.7134574992.169013342
Preoperative Erythrozyten in 1012/L−2.0211631282.701073134−0.7482815260.4542903650.132501260.00066536926.3862472
WHO BMI_obesity class II1.1410748921.6276896010.7010396150.4832782933.1301311090.12884590776.04215731
Stem standard (Yes/No)0.2864573820.512115910.5593604440.5759157521.3317014130.4880822433.633462757
Nadler's total blood volume (mL)−4.9309165138.825035819−0.5587418130.5763379390.0072198832.2215E‐10234646.6055
WHO BMI_obesity class I0.5775213131.0414564950.5545323460.5792145751.7816168830.23137953513.71840738
Weight0.1589386060.3153805190.5039582250.6142907331.1722659750.6317914952.175096571
Preoperative Hemoglobin in g/L0.0825023220.1669869890.4940643740.6212607171.0860011960.7828719281.506502603
Const−32.142371.27517341−0.4509606710.6520178951.09844E‐142.35093E‐755.13232E+46
Sex_male (Yes/No)1.288969813.6185447920.3562122020.7216816543.6290460220.0030177384364.187356
Preoperative MCV in fl0.1477450030.4290251870.3443737270.7305652451.1592172610.5000091342.687520222
48 h postoperative MCH in pg−0.5509382171.727852062−0.3188572850.7498347360.576408760.01949755817.04044429
BMI (kg/m2)−0.1043375830.332454119−0.3138405480.7536421460.900921110.4695710391.7285113
48 h postoperative MCHC in g/l0.042957720.1571888160.2732873840.7846323131.0438937580.7671087531.420547184
WHO BMI_overweight−0.1582908590.602184853−0.262860910.7926577860.8536014690.2622252312.778662692
48 h postoperative MCV in fl0.1163828830.5806885130.2004222230.8411503811.123425930.3599660033.506125053
GT avulsion_Yes−1.6302804248.379076698−0.194565640.8457330040.1958746381.44443E‐082656202.758
Preoperative MCHC in g/l−0.0182556930.119630734−0.1526003570.8787134440.9819099330.7766794031.24137078
Hemoglobin 48 h postoperativ in g/L−0.007405750.049849202−0.1485630570.8818984260.9926216050.9002269421.094499181
WHO BMI_underweight−0.3134647512.245946753−0.1395690930.8890004620.7309101420.00895592959.65094528
Preoperative MCH in pg0.1202306241.3628452020.0882203080.9297015771.1277569090.07801166716.30314666
Preoperative Haematokrit l/l0.62436576152.944483730.0117928390.9905908941.8670614191.60226E‐452.17563E+45
Operator_trainee (Yes/No)−32.5432004914206.3677−0.0022907470.998172257.35644E‐150inf
Dislocation (Yes/No)−26.4952269673548.91203−0.000360240.999712573.11365E‐120inf
Death (Yes/No)21.2743076888859.493680.0002394150.99980897417350597330inf
Indication – cancer (Yes/No)−17.47234785131010.6979−0.0001333660.9998935892.5814E‐080inf

Note: This table presents all 39 predictors included in the final model, along with logistic regression coefficients (β), standard errors (SE), Wald z‐statistics, p‐values, OR, and 95% CI. Significant predictors (cup inclination, 48‐h postoperative hematocrit, and reoperation during the hospital stay) demonstrated independent associations with transfusion risk, while remaining variables did not reach statistical significance but are shown here for transparency and completeness.

Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; CI, confidence interval; DVT, deep vein thrombosis; Hct, hematocrit; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; OR, odds ratio; PE, pulmonary embolism; SE, standard error.

Figure 2
Figure 2. ROC curve of the multivariable logistic regression model predicting perioperative transfusion. The model demonstrated excellent discriminatory performance with an AUC of 0.931, indicating strong separation between transfused and non‐transfused patients. The diagonal line represents the line of no discrimination. AUC, area under the curve; FPR, false positive rate; ROC, receiver operating characteristic; TPR, true positive rate.

Results of Univariate ROC Analyses

When considered as a single predictor, cup inclination yielded an AUC of 0.393, indicating poor discriminatory capability. The Youden‐derived cutoff of < 55° produced very high sensitivity (0.981) but almost negligible specificity (0.0097), resulting in a Youden index of 0.0097 and confirming that inclination alone does not meaningfully distinguish between patients who did and did not receive transfusions. For clinical interpretability, the cutoff was rounded to 55°, which corresponds to commonly accepted target ranges for acetabular cup inclination in THA and reflects routine institutional practice rather than a data‐driven optimization alone.

In contrast, the 48‐h hematocrit showed strong predictive ability with an AUC of 0.817. A threshold of < 0.28 L/L provided a reasonable balance of sensitivity (0.710) and specificity (0.866), yielding a Youden index of 0.575. Positive predictive value at this threshold was 0.535, while the negative predictive value was high at 0.928, indicating that a hematocrit ≥ 0.28 L/L strongly predicted absence of transfusion.

Results of Combined Decision Rules

Using clinically rounded thresholds, the AND rule—defined as cup inclination < 55° and 48‐h hematocrit < 0.28 L/L—demonstrated moderate sensitivity (0.573) and high specificity (0.887), yielding a Youden index of 0.460. The OR rule, which classified patients as high‐risk when either predictor was below threshold, resulted in high sensitivity but extremely poor specificity, producing a Youden index near zero. This indicates that combining the rules with an OR logic does not improve clinical discrimination, whereas the AND rule retains practical diagnostic value (Table 3).

Table 3. Summary of univariate ROC characteristics for cup inclination and 48‐h hematocrit, including Youden‐derived thresholds, sensitivity, specificity, positive and negative predictive values, and model performance of combined AND‐ and OR‐based decision rules.
Predictor/ruleOptimal thresholdAUCSensitivitySpecificityPPVNPVYouden J
Inclination (°)< 55°0.3930.9810.00970.170.710.010
48 h hematocrit (l/l)< 0.28 l/l0.8170.7100.8660.540.930.575
Combined rule (OR)Incl < 55° or Hct < 0.28—0.9810.0097——≈0
Combined rule (AND)Incl < 55° and Hct < 0.28—0.5730.887——0.460

Note: Inclination < 55° showed high sensitivity but nearly zero specificity, confirming poor discriminatory value as a standalone predictor. In contrast, hematocrit < 0.28 L/L achieved balanced sensitivity and specificity and a strong Youden index. The combined AND‐rule (inclination < 55° AND hematocrit < 0.28 L/L) yielded moderate sensitivity and high specificity, providing improved clinical discrimination compared with inclination alone.

Abbreviations: AND, logical conjunction; AUC, area under the curve; OR, logical disjunction; PPV, positive predictive value; NPV, negative predictive value.

Discussion

Summary of Key Findings

In this retrospective evaluation of 8 years of elective primary THA at a certified EPZ, the 48‐h hematocrit emerged as the strongest and most clinically meaningful predictor of perioperative allogeneic transfusion. Cup inclination exhibited statistical significance only within the multivariable model but demonstrated negligible discriminatory ability when examined as an isolated predictor. Reoperation showed a strong association with transfusion, which likely reflects common underlying procedural complexity rather than a direct preoperative risk variable.

Interpretation of 48‐h Hematocrit as the Primary Transfusion Predictor

The 48‐h hematocrit emerged as the most powerful and clinically meaningful predictor of perioperative transfusion, outperforming both inclination and all other demographic and procedural variables. This strong predictive value is physiologically plausible: hematocrit reflects cumulative perioperative blood loss (visible and hidden), hemodilution, and individual patient reserve. The AUC of 0.817 and the optimal cutoff of < 0.28 L/L demonstrate that early postoperative hematocrit accurately captures the net result of intraoperative bleeding, fluid shifts, and ongoing postoperative loss. The high negative predictive value (0.928) further highlights its practical utility, as a hematocrit ≥ 0.28 L/L reliably excludes transfusion need in most cases. Unlike inclination, which operates as a surrogate of technical execution, or reoperation, which reflects postoperative course, hematocrit directly reflects the patient's physiologic state. Its superior discriminative performance confirms that transfusion decisions should be guided primarily by early postoperative hematocrit values rather than radiographic or purely procedural metrics.

Current international transfusion and Patient Blood Management (PBM) guidelines13 primarily base transfusion decisions on hemoglobin thresholds in combination with clinical symptoms rather than on hematocrit values alone. In this context, the 48‐h hematocrit identified in the present study should not be interpreted as an alternative transfusion trigger. Instead, it represents an early postoperative marker that integrates cumulative perioperative blood loss, hemodilution, and individual patient reserve. As such, it complements guideline‐based decision‐making by aiding early risk stratification, while definitive transfusion decisions should remain aligned with established guideline recommendations.

Interpretation of Inclination and Surgical Quality Markers

Despite statistical significance in the multivariable model, cup inclination demonstrated negligible standalone discriminative ability (AUC 0.393) and should therefore not be interpreted as a clinically useful predictor when evaluated in isolation. The conflicting statistical behavior of cup inclination, significant in multivariable analysis yet uninformative as a stand‐alone threshold, suggests that inclination functions primarily as a surrogate indicator of surgical technique rather than a biomechanically independent determinant of blood loss. A flatter, controlled inclination, as long as it is not pathologically shallow, typically corresponds with gentler exposure, balanced soft tissue tension, and more refined acetabular preparation. These technical nuances can reduce intraoperative bleeding. Thus, inclination contributes only in the context of multivariable relationships, reflecting operative quality rather than representing a direct causal predictor.

Interpretation of Reoperation as Marker of Operative Difficulty

Reoperation represents a downstream postoperative outcome and should be interpreted as a marker of underlying perioperative complexity rather than a preoperative predictor. Reoperation in this dataset refers to subsequent revision surgery or hematoma evacuation, often occurring days to months after the primary procedure. Its strong association with transfusion likely arises from shared underlying intraoperative difficulty. Cases that later required revision frequently represent technically demanding or complication‐prone surgeries characterized by increased preoperative deformity, greater implant manipulation, abnormal anatomy, or surgeon‐related complexity. Consequently, transfusion and future revision surgery may represent parallel outcomes of the same initial surgical stressors rather than an independent predictive pathway.

Value of Cutoff‐Based Decision Rules

Cutoff‐based decision rules, although attractive for clinical simplicity, demonstrated clear limitations in this study. The poor performance of the OR‐based decision rule is explained by the opposing discriminative properties of the two variables. Cup inclination showed extremely high sensitivity but almost no specificity, whereas 48‐h hematocrit demonstrated balanced sensitivity and specificity. When combined using an OR logic, the low‐specificity component dominates, resulting in a high false‐positive rate and a Youden index close to zero. In contrast, the AND rule mitigates this effect by requiring concordance of both criteria, thereby improving specificity and overall clinical usefulness. The inclination threshold (< 55°) exhibited excellent sensitivity but essentially zero specificity, confirming that cup position alone cannot be used to guide perioperative blood management decisions. In contrast, the 48‐h hematocrit threshold (< 0.28 L/L) preserved both sensitivity and specificity, producing a Youden index of 0.575 and demonstrating strong negative predictive ability. Combined decision rules revealed that an AND logic could modestly improve clinical precision, whereas an OR logic offered no meaningful benefit. These observations highlight that only hematocrit retains clinical utility as a threshold‐based predictor, whereas inclination should not be reduced to a binary risk rule.

Relationship to Relevant Evidence

Sehat et al.14 showed that “hidden” blood loss constitutes a substantial proportion of total perioperative blood loss after arthroplasty and should be considered when estimating true blood loss. Carson et al.15 summarized randomized trial evidence supporting restrictive red blood cell transfusion thresholds (including around 8 g/dL in orthopedic surgery) and emphasized integrating hemoglobin with clinical context. Rosencher et al.16 reported wide variability in European blood management practices and demonstrated that computed blood loss markedly exceeded estimated intraoperative loss, with baseline hemoglobin strongly influencing allogeneic transfusion probability. Goodnough and Shander17 outlined patient blood management as a multidisciplinary, evidence‐based strategy to optimize anemia management and minimize transfusion exposure and related risks. Patel et al.18 found that topical TXA achieved similar reductions in perioperative hemoglobin decline as intravenous TXA in a randomized arthroplasty setting, supporting pharmacologic blood‐sparing approaches.

For primary THA approaches, a 20‐RCT analysis (n = 1501) found SuperPATH to bleed ~82 mL less than posterior approach (MD −81.75 mL), while direct anterior approach bled ~92 mL more than posterior approach (MD +91.87 mL) and ~174 mL more than SuperPATH in indirect comparison (MD +173.62 mL); reported study‐level means spanned 89–1108 mL for SuperPATH, 166–391 mL for direct anterior approach, and 123.8–844.6 mL for posterior approach19. Beyond approach and procedure, meta‐regression across RCTs of SuperPATH vs. conventional hemiarthroplasty identified intraoperative blood loss (alongside age, mobilization timing, and incision length) as a significant predictor of early Harris Hip Score (HHS), reinforcing the causal plausibility that greater bleeding degrades early function20. Taken together, these quantitative gradients (tens to hundreds of milliliters across techniques) are consistent with our finding that early postoperative hematocrit is an effective proxy for cumulative perioperative bleeding, whereas a simple inclination cutoff adds little discrimination unless interpreted as a surrogate of operative technique quality.

Clinical Implications

The findings have immediate relevance for perioperative blood management in THA performed within EPZ‐certified environments: (1) routine early postoperative hematocrit measurement (≤ 48 h) should be emphasized as the primary indicator for transfusion risk assessment; (2) cup inclination should not be used as an independent trigger for transfusion decisions; its predictive value only emerges when interpreted in relation to overall surgical technique quality; (3) enhanced intraoperative vigilance is warranted in technically challenging cases, as both transfusion and future reoperation appear to originate from underlying surgical difficulty rather than isolated risk variables; (4) clinical decision‐making may benefit from a pragmatic AND‐based combined rule (inclination + Hct), although hematocrit alone remains more efficient (Figure 3); (5) reoperation should be viewed as a retrospective marker of case complexity, not as a prospective stratification factor. As this was a single‐center study conducted in a certified Endoprosthetic Center with standardized perioperative workflows, the findings reflect a controlled high‐volume setting and may not be fully generalizable to institutions with different structures or surgical volumes.

Figure 3
Figure 3. Combined cutoff‐based decision rule for transfusion risk after primary THA. This flowchart illustrates the clinically rounded thresholds derived from ROC analysis. Patients meeting both criteria—cup inclination < 55° AND 48‐h hematocrit < 0.28 L/L—show a markedly elevated transfusion risk. In contrast, patients above either threshold demonstrate a low transfusion probability, with a negative predictive value of 0.93. The visualized rule highlights practical bedside applicability and supports rapid stratification in EPZ‐standard perioperative workflows. EPZ, endoprosthetic center; THA, total hip arthroplasty.

Limitations

Several limitations must be acknowledged: (1) The retrospective design does not allow causal inference and may introduce documentation‐related biases. (2) Missing data were managed by complete‐case analysis, which may reduce power or introduce selection bias. (3) Multicollinearity was not formally assessed despite the inclusion of multiple correlated hematologic parameters and consequently, individual odds ratios—particularly for laboratory variables—should not be interpreted causally, and the regression results should be viewed as exploratory; (4) No internal validation (e.g., bootstrapping or cross‐validation) was performed. Consequently, the reported AUC may overestimate true predictive performance due to model complexity, the high number of predictors relative to transfusion events, and potential overfitting. The discriminative performance should therefore be interpreted as exploratory. (5) Reoperation is a postoperative event and cannot be used for prospective risk stratification; its association with transfusion reflects shared perioperative complexity rather than predictive utility; (6) As this was a single‐center EPZ study, external generalizability may be limited but reflects real‐world standardized workflows in a high‐volume certified environment; (7) Statistical significance of variables with low discriminative performance does not imply meaningful clinical discrimination and should be interpreted with caution; (8) The extremely strong association of the 48‐h hematocrit with transfusion suggests quasi‐separation within the logistic regression model, resulting in numerically extreme odds ratios; therefore, effect sizes should not be interpreted literally; (9) The single‐center design limits external validity, and the findings may not be directly generalizable to non‐certified centers or institutions with different perioperative workflows; (10) Cup inclination measurements were derived from routine postoperative radiographs, and no formal inter‐ or intra‐observer reliability analysis was performed, which may have introduced measurement variability; (11) Although institutional transfusion standards were applied throughout the study period, temporal or physician‐related variability in transfusion decisions cannot be completely excluded due to the retrospective design; (12) All associations identified in the multivariable analysis should be interpreted cautiously, as the model was explicitly exploratory, non‐validated, and not designed for causal inference. Statistically significant predictors are therefore discussed as signals of association rather than definitive determinants of transfusion risk.

Conclusion

Postoperative 48‐h hematocrit is a strong and clinically actionable marker associated with perioperative transfusion in primary THA. Cup inclination should be interpreted as an indirect proxy of surgical quality rather than an isolated predictor, while reoperation reflects underlying complexity rather than a preoperative risk factor. Hematocrit‐based thresholds may support early postoperative risk stratification for transfusion, whereas inclination‐based cutoffs lack discriminative power. These findings support the use of early postoperative laboratory markers for transfusion risk assessment, rather than isolated radiographic or intraoperative parameters.

Author Contributions

Nikolai Ramadanov: conceptualization, investigation, funding acquisition, writing – original draft, writing – review and editing, visualization, validation, methodology, software, formal analysis, supervision, data curation, project administration, resources. Dakota Fuchs: investigation, data curation, methodology. Maximilian Heinz: conceptualization, writing – original draft. Robert Prill: writing – review and editing, supervision. Roland Becker: writing – review and editing, supervision.

Funding

The authors have nothing to report.

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgements

Open Access funding enabled and organized by Projekt DEAL.

Declarations

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Sources

References

20 references, in the article's own order. Citation numbers in the text are this list's numbers (20 records are cited).

  1. Allogeneic Blood Transfusion Is a Significant Risk Factor for Surgical‐Site Infection Following Total Hip and Knee Arthroplasty: A Meta‐Analysis

    Kim J. L., Park J.‐H., Han S.‐B., Cho I. Y., Jang K.‐M.

    2017Journal of Arthroplasty 32:320–325 · PMID 27682006doi:10.1016/j.arth.2016.08.026

  2. Risk Factors for Perioperative Blood Transfusion in Total Hip Arthroplasty: A Meta‐Analysis

    Peng C., Qiao L.

    2025BMC Musculoskeletal Disorders 26:569 · PMID 40483471doi:10.1186/s12891-025-08801-x

  3. Blood Transfusion in Elective Total Hip Arthroplasty : Can Patient‐Specific Parameters Predict Transfusion?

    Meißner N., Strahl A., Rolvien T., Halder A. M., Schrednitzki D.

    2024Bone & Joint Open 5:560–564 · PMID 38971574doi:10.1302/2633-1462.57.BJO-2023-0157.R1

  4. Predictors for Blood Loss and Transfusion Frequency to Guide Blood Saving Programs in Primary Knee‐ and Hip‐Arthroplasty

    Pempe C., Werdehausen R., Pieroh P.

    2021Scientific Reports 11:4386 · PMID 33623079doi:10.1038/s41598-021-82779-z

  5. Quantifying Blood Loss and Transfusion Risk After Primary vs Conversion Total Hip Arthroplasty

    Newman J. M., Webb M. R., Klika A. K., Murray T. G., Barsoum W. K., Higuera C. A.

    2017Journal of Arthroplasty 32:1902–1909 · PMID 28236548doi:10.1016/j.arth.2017.01.038

  6. Systematic Review, Meta‐Analysis and Meta‐Regression of the Effect of Tranexamic Acid on Surgical Blood Loss

    Ker K., Prieto‐Merino D., Roberts I.

    2013British Journal of Surgery 100:1271–1279 · PMID 23839785doi:10.1002/bjs.9193

  7. The Efficacy of Tranexamic Acid in Total Hip Arthroplasty: A Network Meta‐Analysis

    Fillingham Y. A., Ramkumar D. B., Jevsevar D. S.

    2018Journal of Arthroplasty 33:3083–3089.e4 · PMID 30007789doi:10.1016/j.arth.2018.06.023

  8. On the Relevance of Preoperative Haemoglobin Optimisation Within a Patient Blood Management Programme for Elective Hip Arthroplasty Surgery

    Pinilla‐Gracia C., Mateo‐Agudo J., Herrera A., Muñoz M.

    2020Blood Transfusion 18:182–190 · PMID 32281924doi:10.2450/2020.0057-20

  9. Impact of Preoperative Anemia on Patients Undergoing Total Joint Replacement of Lower Extremity: A Systematic Review and Meta‐Analysis

    Zhang F.‐Q., Yang Y.‐Z., Li P.‐F.

    2024Journal of Orthopaedic Surgery and Research 19:249 · PMID 38637795doi:10.1186/s13018-024-04706-y

  10. Blood Transfusion Rate and Related Complications After Hip Arthroplasty Using Patient Blood Management: A Case‐Control Study

    Yoo J.‐Y., Yoo J.‐I., Ha Y.‐C.

    2025Clinical Orthopaedics and Surgery 17:582 · PMID 40785769doi:10.4055/cios25072

  11. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

    von Elm E., Altman D. G., Egger M.

    2007PLoS Medicine 4(10):e296 · PMID 17941714doi:10.1371/journal.pmed.0040296

  12. Prediction of Blood Volume in Normal Human Adults

    Nadler S. B., Hidalgo J. H., Bloch T.

    1962Surgery 51(2):224–232 · PMID 21936146

  13. International Consensus Statement on the Peri‐Operative Management of Anaemia and Iron Deficiency

    Muñoz M., Acheson A. G., Auerbach M.

    2017Anaesthesia 72(2):233–247 · PMID 27996086doi:10.1111/anae.13773

  14. Hidden Blood Loss Following Hip and Knee Arthroplasty. Correct Management of Blood Loss Should Take Hidden Loss Into Account

    Sehat K. R., Evans R. L., Newman J. H.

    2004Journal of Bone and Joint Surgery British Volume 86(4):561–565 · PMID 15174554

  15. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage

    Carson J. L., Guyatt G., Heddle N. M.

    2016Journal of the American Medical Association 316(19):2025–2035 · PMID 27732721doi:10.1001/jama.2016.9185

  16. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) Study: Blood Management in Elective Knee and Hip Arthroplasty in Europe

    Rosencher N., Kerkkamp H. E., Macheras G.

    2003Transfusion 43(4):459–469 · PMID 12662278doi:10.1046/j.1537-2995.2003.00348.x

  17. Patient blood management

    Goodnough L. T., Shander A.

    2012Anesthesiology 116(6):1367–1376 · PMID 22487863doi:10.1097/ALN.0b013e318254d1a3

  18. Comparison of Intravenous Versus Topical Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Study

    Patel J. N., Spanyer J. M., Smith L. S., Huang J., Yakkanti M. R., Malkani A. L.

    2014Journal of Arthroplasty 29(8):1528–1531 · PMID 24768543doi:10.1016/j.arth.2014.03.011

  19. Direct and Indirect Comparisons in Network Meta‐Analysis of SuperPATH, Direct Anterior and Posterior Approaches in Total Hip Arthroplasty

    Ramadanov N., Bueschges S., Liu K., Lazaru P., Marintschev I.

    2022Scientific Reports 12(1):16778 · PMID 36202828doi:10.1038/s41598-022-20242-3

  20. Patient‐Related Predictors for the Functional Outcome of SuperPATH Hemiarthroplasty Versus Conventional Approach Hemiarthroplasty: A Systematic Review and Meta‐Regression Analysis of Randomized Controlled Trials

    Ramadanov N., Voss M., Hable R.

    2024Orthopaedic Surgery 16(4):791–801 · PMID 38298174doi:10.1111/os.14006

Article record

The record

Status

Living reprint · journal article Journal version available

Status
Version of record: Orthopaedic Surgery 2026
Journal version
Orthopaedic Surgery (2026) · doi:10.1111/os.70270
Confirmed
2026-02-10
Licence
CC BY 4.0

This reprint has no DOI of its own: cite the journal article.

The journal's version is the version of record. This page re-typesets it under the article's licence; where they differ, the journal's version is authoritative.

Version history

  1. Published in Orthopaedic Surgery2026-02-10
  2. Living reprint on Literature Decoded2026-10-01
  3. Reprinted here2026-10-01
  4. This HTML2026-10-01

Cite this article

Citation
Ramadanov N, Fuchs D, Heinz M, Prill R, Becker R. Perioperative Factors Associated With Allogeneic Blood Transfusion in Elective THA. Orthop Surg. 2026;18(3):576–586. doi:10.1111/os.70270
BibTeX
@article{Ramadanov2026Perioperative,
  title     = {Perioperative Factors Associated With Allogeneic Blood Transfusion in Elective THA},
  author    = {Nikolai Ramadanov and Dakota Fuchs and Maximilian Heinz and Robert Prill and Roland Becker},
  journal   = {Orthopaedic Surgery},
  year      = {2026},
  volume    = {18},
  number    = {3},
  pages     = {576–586},
  doi       = {10.1111/os.70270},
  pmid      = {41668439},
  publisher = {Wiley}
}
RIS
TY  - JOUR
TI  - Perioperative Factors Associated With Allogeneic Blood Transfusion in Elective THA
AU  - Nikolai Ramadanov
AU  - Dakota Fuchs
AU  - Maximilian Heinz
AU  - Robert Prill
AU  - Roland Becker
JO  - Orthopaedic Surgery
PY  - 2026
VL  - 18
IS  - 3
SP  - 576
EP  - 586
DO  - 10.1111/os.70270
PB  - Wiley
SN  - 1757-7853
UR  - https://doi.org/10.1111/os.70270
ER  - 

Cite the original article (the version of record), not this reprint.

Take it with you

One self-contained HTML file: the text, data and figures, readable offline.

Disclaimer and limitations

Educational summary of research findings; not medical advice. Discuss care decisions with a qualified clinician.

The findings apply to the included study populations and may not generalise to every person or setting.

Licence and attribution

This page reproduces Perioperative Factors Associated With Allogeneic Blood Transfusion in Elective THA by Nikolai Ramadanov, Dakota Fuchs, Maximilian Heinz, Robert Prill, Roland Becker, first published in Orthopaedic Surgery 2026;18(3):576–586, doi:10.1111/os.70270, PMID 41668439, PMC12967687. © 2026 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd. It is used under the CC BY 4.0 licence.

Changes made:

The words, data, figures and conclusions are the authors’. Literature Decoded is not the publisher of record and does not claim endorsement by the authors or the journal. The version of record is the journal’s; cite it.

Licence statement in the article: “This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.”

Are you an author of this article? Claim it or ask us to take it down.

Cite this article

Living reprint · journal article